Skip to main content

Snapdragon acquisition falls through

The proposed acquisition of US-based Snapdragon Chemistry by the Chinese CDMO Asymchem Laboratories has been abandoned. The two firms were unable to agree mitigation terms that would satisfy the US Treasury’s Committee on Foreign Investment in the United States (CFIUS).

Evonik in hydroformylation breakthrough

A research team involving Evonik and the Leibniz Institute for Catalysis (LIKAT) in germany has claimed a breakthrough in hydroformylation, an important reaction in industrial organic chemistry where unsaturated compounds are converted into aldehydes and alcohols using synthesis gas. This has been published in Science.

SK Capital invests into VanDeMark

SK Capital Partners have made an investment in VanDeMark Chemical in partnership with Comvest Partners, which has been a co-owner since 2019. The amount involved was not disclosed but VanDeMark said that this would “serve as a catalyst for a new strategic direction as the company seeks to deepen and expand its presence in fine chemistries for the global life science market”.

Innovation hub for Evonik

Evonik has opened a $2.5 million ‘innovation hub’ at its site in Allentown, Pennsylvania. Described as part of its broader globalisation strategy for RD&I, this comprises several testing and processing labs, a pilot plant and a newly designed collaboration space “to support a hybrid and creative work environment”. In all, it will create 50 jobs for scientists, engineers and lab technicians, in addition to 300 already there.

Seatex acquires ChemQuest Chemicals

Speciality chemical manufacturer and formulator Seatex has acquired ChemQuest Chemicals, a custom chemical manufacturer, with immediate effects. Terms were not disclosed. Both companies are based in Texas.

Seatex said that this will give it “enhanced production capabilities, increased capacity and a complementary customer base, representing a diverse set of end-markets”, while also making it one of the largest custom toll manufacturers in the state.

Kallo gets biological wastewater treatment plant

At a cost of €12 million and in response to environmental legislation, Lanxess has commissioned a new biological wastewater treatment plant at its site at Kallo, near Antwerp. This has a capacity of 260,000 L/hour and also treats wastewater from two other companies. The site makes rubber chemicals and glass fibres.

Subscribe to Current issue